# OnCo record nutrition-lifestyle-roadmap (roadmap). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/roadmaps/nutrition-lifestyle-roadmap/>
  a schema:CreativeWork ;
  onco:kind "roadmap" ;
  schema:identifier "nutrition-lifestyle-roadmap" ;
  schema:name "Diet, exercise and lifestyle roadmap: causes established → interventions that disappointed → exercise proven as treatment"@en ;
  schema:description "What people eat, weigh and do shapes who gets cancer and how treatment goes. Decades of trials separated what is established (obesity, alcohol and inactivity cause cancer; exercise after treatment reduces recurrence) from what is hype, and the next questions are being asked with the rigour of a drug trial."@en ;
  schema:url <https://onco.cc/roadmaps/nutrition-lifestyle-roadmap/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.nejm.org/doi/full/10.1056/NEJMoa2502760>, <https://www.nejm.org/doi/full/10.1056/NEJMsr1606602> ;
  onco:related <https://onco.cc/ideas/idea-exercise-as-adjuvant/>, <https://onco.cc/ideas/idea-bio2-exercise-reimbursement/>, <https://onco.cc/ideas/idea-nl-exercise-dose-finding/>, <https://onco.cc/ideas/idea-bio2-prehabilitation-standard/>, <https://onco.cc/ideas/idea-prev-glp1-cancer-prevention-rct/>, <https://onco.cc/ideas/idea-prev-glp1-endometrial-hyperplasia/>, <https://onco.cc/ideas/idea-bio2-gdf15-plus-exercise/>, <https://onco.cc/ideas/idea-cachexia-gdf15-prevention/>, <https://onco.cc/ideas/idea-nl-sleep-circadian-survivorship-rct/>, <https://onco.cc/ideas/idea-moon-integrative-oncology-bridge/>, <https://onco.cc/ideas/idea-prev-alcohol-cancer-warning-labels/>, <https://onco.cc/ideas/idea-prev-minimum-unit-pricing-cancer-endpoints/>, <https://onco.cc/companies/maat-pharma/>, <https://onco.cc/roadmaps/survivorship-roadmap/>, <https://onco.cc/roadmaps/prevention-roadmap/> ;
  onco:sections <https://onco.cc/fronts/nutrition-lifestyle/> ;
  onco:technologies <https://onco.cc/technologies/exercise-oncology/>, <https://onco.cc/technologies/structured-exercise-survivorship/>, <https://onco.cc/technologies/exercise-during-chemotherapy/>, <https://onco.cc/technologies/prehabilitation/>, <https://onco.cc/technologies/eras-perioperative-nutrition/>, <https://onco.cc/technologies/oncology-nutrition/>, <https://onco.cc/technologies/nutrition-screening-mnt/>, <https://onco.cc/technologies/enteral-parenteral-nutrition/>, <https://onco.cc/technologies/immunonutrition-perioperative/>, <https://onco.cc/technologies/dietitian-led-weight-loss-breast/>, <https://onco.cc/technologies/mediterranean-plant-forward-diet/>, <https://onco.cc/technologies/dietary-fibre-microbiome-io/>, <https://onco.cc/technologies/fmt-checkpoint-nonresponders/>, <https://onco.cc/technologies/probiotics-antibiotic-stewardship-io/>, <https://onco.cc/technologies/microbiome-modulation-io/>, <https://onco.cc/technologies/glp1-agonists-cancer-risk/>, <https://onco.cc/technologies/bariatric-surgery-cancer-incidence/>, <https://onco.cc/technologies/fasting-mimicking-diet/>, <https://onco.cc/technologies/ketogenic-diet-glioblastoma/>, <https://onco.cc/technologies/time-restricted-eating/>, <https://onco.cc/technologies/cachexia-therapy/>, <https://onco.cc/technologies/cachexia-appetite-pharmacotherapy/>, <https://onco.cc/technologies/resistance-training-cachexia/>, <https://onco.cc/technologies/sleep-circadian-interventions/>, <https://onco.cc/technologies/vitamin-d-omega3-supplementation/>, <https://onco.cc/technologies/omega3-epa-cachexia/>, <https://onco.cc/technologies/high-dose-vitamin-c/>, <https://onco.cc/technologies/dietary-supplements-treatment-interactions/>, <https://onco.cc/technologies/alcohol-reduction-labelling/>, <https://onco.cc/technologies/red-processed-meat-reduction/>, <https://onco.cc/technologies/ultra-processed-food-ssb/>, <https://onco.cc/technologies/smoking-cessation-after-diagnosis/>, <https://onco.cc/technologies/integrative-oncology/>, <https://onco.cc/technologies/yoga-cancer/> ;
  onco:companies <https://onco.cc/companies/cctg/> ;
  onco:institutions <https://onco.cc/institutions/espen/>, <https://onco.cc/institutions/iarc/> ;
  onco:terms <https://onco.cc/terms/obesity-related-cancers/>, <https://onco.cc/terms/risk-factor/>, <https://onco.cc/terms/cachexia/>, <https://onco.cc/terms/sarcopenia/>, <https://onco.cc/terms/gut-microbiome-diversity/>, <https://onco.cc/terms/metabolic-syndrome/>, <https://onco.cc/terms/malnutrition-screening/>, <https://onco.cc/terms/warburg-effect-diet-claims/>, <https://onco.cc/terms/unproven-diet-claims/>, <https://onco.cc/terms/dietary-pattern-scores/> ;
  onco:trials <https://onco.cc/trials/challenge/>, <https://onco.cc/trials/bwel/>, <https://onco.cc/trials/whel/>, <https://onco.cc/trials/vital/>, <https://onco.cc/trials/ergo2/>, <https://onco.cc/trials/fmt-pd1-refractory-melanoma-pitt/>, <https://onco.cc/trials/mimic-01/>, <https://onco.cc/trials/ponsegromab-phase-2/>, <https://onco.cc/trials/olanzapine-appetite-tmh/>, <https://onco.cc/trials/prehab-trial/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-cachexia-supportive/>, <https://onco.cc/bottlenecks/b-prevention-adoption/>, <https://onco.cc/bottlenecks/b-misinformation/>, <https://onco.cc/bottlenecks/b-generic-repurposing/>, <https://onco.cc/bottlenecks/b-funding-allocation/> .